000 01417 a2200385 4500
005 20250518043247.0
264 0 _c20200127
008 202001s 0 0 eng d
022 _a1365-4632
024 7 _a10.1111/ijd.14542
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Xiran
245 0 0 _aProgrammed cell death protein 1 and vitiligo.
_h[electronic resource]
260 _bInternational journal of dermatology
_cSep 2019
300 _a1102-1103 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aB7-H1 Antigen
_xgenetics
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aMelanocytes
_xdrug effects
650 0 4 _aProgrammed Cell Death 1 Ligand 2 Protein
_ximmunology
650 0 4 _aProgrammed Cell Death 1 Receptor
_xagonists
650 0 4 _aRecombinant Fusion Proteins
_xgenetics
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSkin
_xcytology
650 0 4 _aSkin Pigmentation
_xdrug effects
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aVitiligo
_xdrug therapy
700 1 _aMeng, Xianmin
700 1 _aSong, Zhiqi
773 0 _tInternational journal of dermatology
_gvol. 58
_gno. 9
_gp. 1102-1103
856 4 0 _uhttps://doi.org/10.1111/ijd.14542
_zAvailable from publisher's website
999 _c29775488
_d29775488